What Happened? Shares of lab services company Charles River Laboratories (NYSE:CRL) jumped 7.5% in the morning session after ...

Shares of Charles River Laboratories International Inc. advanced 9.06% to $163.36 Tuesday, on what proved to be an all-around ...

Charles River Laboratories International, Inc provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and ...

Charles River Laboratories International Inc. (NYSE: CRL), fresh from the collapse of a proposed, $1.6 billion merger with WuXi PharmaTech (Cayman) Inc. (NYSE: WX), plans to accelerate a $300 ...

Charles River Laboratories is down 10.9% during the same time and is heading into earnings with an average analyst price target of $155.28 (compared to the current share price of $119.44).

Charles River Laboratories is down 10% during the same time and is heading into earnings with an average analyst price target of $193.34 (compared to the current share price of $151.10).

Charles River Laboratories International, Inc. today reported its results for the third quarter of 2023. For the quarter, revenue was $1.03 billion, an increase of 3.8% from $989.2 million in the ...

Charles River Laboratories International, Inc. announced today that it has acquired Retrogenix Limited, an early-stage contract research organization providing specialized bioanalytical services ...

What's happening. On May 6, Elliott and Charles River Laboratories entered into a cooperation agreement in which four incumbent directors won't seek re-election and the following four individuals ...

Charles River announces long-term solar contract for North American operations, moves closer to goal of sourcing 100% renewable electricity by 2030.

Charles River Laboratories International, Inc. (NYSE: CRL) today announced that four new directors will join its Board of Directors and that four long-time members of the Board will not seek re ...

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it will appoint Flavia H. Pease as its next Chief Financial Officer, succeeding ...